58 results
424B3
PRE
Prenetics Global Limited - Ordinary Shares
16 Feb 24
Prospectus supplement
6:13am
and registration with the Medical Device Division of the Department of Health of Hong Kong in the Medical Device Administrative Control System, for which
F-3
PRE
Prenetics Global Limited - Ordinary Shares
17 Jan 24
Shelf registration (foreign)
6:59am
of the Department of Health of Hong Kong in the Medical Device Administrative Control System, for which the applicant must demonstrate the safety
F-3
EX-10.25
PRE
Prenetics Global Limited - Ordinary Shares
17 Jan 24
Shelf registration (foreign)
6:59am
-governmental, public or statutory authority of any nature (including any governmental division, department, agency, regulatory or administrative authority
6-K
PRE
Prenetics Global Limited - Ordinary Shares
30 Nov 23
Current report (foreign)
6:08am
Department of the Nasdaq Stock Market LLC (“Nasdaq”), dated November 29, 2023, indicating that the Company has regained compliance with the minimum bid
424B3
PRE
Prenetics Global Limited - Ordinary Shares
2 Nov 23
Prospectus supplement
4:04pm
728 King’s Road, Hong Kong
Tel: 852-2210 9588
Attention: Investor Relations Department
FORWARD-LOOKING STATEMENTS
This prospectus and any prospectus … , medical device manufacturers may voluntarily complete an application and registration with the Medical Device Division of the Department of Health
POS AM
ep0ewarg8adtoadgu92
6 Oct 23
Prospectus update (post-effective amendment)
1:52pm
F-3
6wmum fh1gmtr
29 Sep 23
Shelf registration (foreign)
9:17am
424B3
5ls3ln20mbalo
21 Jul 23
Prospectus supplement
6:16am
POS AM
EX-10.23
zb4ao03
6 Jul 23
Prospectus update (post-effective amendment)
9:00am
POS AM
EX-10.24
g0rzldgqh16uhtojyd
6 Jul 23
Prospectus update (post-effective amendment)
9:00am
POS AM
0n0ay6ii
6 Jul 23
Prospectus update (post-effective amendment)
9:00am
POS AM
rm2ovi
31 May 23
Prospectus update (post-effective amendment)
8:25am
POS AM
qad2zvosa53mu9e7w
1 May 23
Prospectus update (post-effective amendment)
5:19pm
6-K/A
EX-99.1
h6topkkqo9ukes47d8aq
1 May 23
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
4:03pm
6-K
EX-99.1
awv6n gb3fca05x
16 Dec 22
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
8:06am
POS AM
4rlbs
14 Dec 22
Prospectus update (post-effective amendment)
8:04am
424B3
1zu6qo8hdml9
1 Jul 22
Prospectus supplement
4:10pm